Atlanta, GANCT07608796Now EnrollingIRB Ready

Depressive Symptoms Clinical Trial in Atlanta, GA

Access cutting-edge depressive symptoms treatment through this phase 2 clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.

Sponsored by Emory University

Quick Self-Assessment

See if you qualify for this Atlanta location

Preparing your pre-screening questions…

Expert Care in Atlanta

Access depressive symptoms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related depressive symptoms treatment provided free

Apply for This Atlanta Location

Check if you qualify for this depressive symptoms clinical trial in Atlanta, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Atlanta

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Atlanta site if eligible
  4. 4Begin participation

About This Depressive Symptoms Study in Atlanta

This study is being done to learn more about the role of inflammation in depressive and cognitive symptoms in patients with depression who have played at least 11 years of organized tackle football. This will be evaluated using a medication called baricitinib, which blocks one aspect of inflammation.

Sponsor: Emory University

Who Can Participate

Inclusion Criteria

willing and able to give written informed consent
playing tackle football for at least 11 years
30-55 years of age
Current Diagnostic and Statistical Manual (DSM)-V major depression or Bipolar, depressed type; or DSM-V major depression or Bipolar, depressed type in partial remission as diagnosed by the Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorders (SCID)-V
score of \>10 on the PHQ-9 from screening and HAM-D score ≥16 for study entry
off all antidepressant or other psychotropic therapy (e.g., mood stabilizers, antipsychotics, and sedative hypnotics) for at least 4 weeks before baseline visit (8 weeks for fluoxetine) or on a stable psychotropic regimen for at least 4 weeks (and no planned changes)
CRP ≥3 mg/L
PHQ-9 anhedonia (item #1) and cognitive (item #7) scores ≥2

Exclusion Criteria

current or history of past autoimmune disorder
history or evidence (clinical or laboratory) of hepatitis B or C infection or human immunodeficiency virus infection
history of any type of cancer requiring treatment with more than minor surgery
unstable cardiovascular, endocrinologic, hematologic, hepatic, renal, or neurologic disease (as determined by physical examination, EKG, and laboratory testing)
significant hematological abnormalities at screening (ANC \< 1500, Hgb\<10, platelet\< 100,000)
history of progressive multifocal leukoencephalopathy
history of deep venous thrombosis
history of cardiovascular disease (coronary artery disease, congestive heart failure, stroke - controlled hypertension is OK)
major surgery within 6 months before screening, or will require major surgery during the study
current or recent (\<4 weeks before study start) viral (including COVID-19), bacterial, fungal, or parasitic infection, or any other active or recent infection
symptomatic herpes zoster infection at or within 12 weeks of study start
history of disseminated/complicated herpes zoster (for example, ophthalmic zoster or CNS involvement)
cirrhosis of the liver from any cause
Additional exclusion criteria apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT07608796) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Depressive Symptoms Treatment Options in Atlanta, GA

If you're searching for depressive symptoms treatment options in Atlanta, GA, this clinical trial (NCT07608796) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced depressive symptoms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all depressive symptoms clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Atlanta, GA

See all multiple sclerosis clinical trials recruiting in Atlanta — not just this study.

Browse Multiple Sclerosis Trials in Atlanta →

Browse More Trials by Condition

Multiple Sclerosis TrialsAll Conditions →

Ready to Join in Atlanta?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Atlanta, GA